MedTrace Logo

Serun Fluoride and Kidney Transplant

NCT03373266 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-12-14

No results posted yet for this study

Summary

Our primary goal is to investigate any hidden burden upon the grafted kidney from the increase of serum fluoride resulted from sevoflurane, versus isoflurane.

Conditions

  • Kidney Transplant; Complications

Interventions

DRUG

Sevoflurane

anesthesia was maintained with Sevoflurane 1-2%.

DRUG

Isoflurane

anesthesia was maintained with isoflurane 1-2%.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Abdelrady S Ibrahim, M.D. · assiut university faculty of medicine

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2017-08-31
Completion
2017-10-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03373266 on ClinicalTrials.gov